New CapitalVenture Capital

John McKearn
RiverVest Venture Partners first closed its fourth fund late last year with a continued mission to bankroll drug and medical device projects that target unmet medical needs. Eight investments ? including three new companies ? later, the St… […]

Parisian venture capital firm Kurma Partners is raising the bar. It?had set its sights on its biggest-ever fund?? the Kurma Biofund III?? with a target of??150 million (about $170 million), backed by marquee investors including Servier, Bpifrance and I… […]